Virax Biolabs Group Limited (VRAX)

Virax Biolabs Group Statistics

Total Valuation

VRAX has a market cap or net worth of $4.95 million. The enterprise value is -$1.74 million.

Market Cap	4.95M
Enterprise Value	-1.74M

Important Dates

The last earnings date was Wednesday, February 5, 2025, before market open.

Earnings Date	Feb 5, 2025
Ex-Dividend Date	n/a

Share Statistics

VRAX has 4.34 million shares outstanding. The number of shares has increased by 50.43% in one year.

Current Share Class	4.34M
Shares Outstanding	4.34M
Shares Change (YoY)	+50.43%
Shares Change (QoQ)	+38.70%
Owned by Insiders (%)	6.63%
Owned by Institutions (%)	1.46%
Float	3.83M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	36.50
Forward PS	n/a
PB Ratio	0.58
P/TBV Ratio	0.59
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.58, with a Debt / Equity ratio of 0.07.

Current Ratio	11.58
Quick Ratio	10.67
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-148.24

Financial Efficiency

Return on equity (ROE) is -90.63% and return on invested capital (ROIC) is -51.27%.

Return on Equity (ROE)	-90.63%
Return on Assets (ROA)	-47.66%
Return on Invested Capital (ROIC)	-51.27%
Return on Capital Employed (ROCE)	-71.77%
Revenue Per Employee	$4,992
Profits Per Employee	-$387,077
Employee Count	17
Asset Turnover	0.01
Inventory Turnover	0.27

Taxes

Income Tax	-136,661
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +66.65% in the last 52 weeks. The beta is 1.79, so VRAX's price volatility has been higher than the market average.

Beta (5Y)	1.79
52-Week Price Change	+66.65%
50-Day Moving Average	1.63
200-Day Moving Average	1.97
Relative Strength Index (RSI)	36.43
Average Volume (20 Days)	129,302

Short Selling Information

The latest short interest is 158,623, so 3.65% of the outstanding shares have been sold short.

Short Interest	158,623
Short Previous Month	202,619
Short % of Shares Out	3.65%
Short % of Float	4.15%
Short Ratio (days to cover)	0.81

Income Statement

In the last 12 months, VRAX had revenue of $84,872 and -$6.58 million in losses. Loss per share was -$2.47.

Revenue	84,872
Gross Profit	33,598
Operating Income	-6.28M
Pretax Income	-6.92M
Net Income	-6.58M
EBITDA	-6.12M
EBIT	-6.28M
Loss Per Share	-$2.47

Balance Sheet

The company has $7.38 million in cash and $603,202 in debt, giving a net cash position of $6.78 million or $1.56 per share.

Cash & Cash Equivalents	7.38M
Total Debt	603,202
Net Cash	6.78M
Net Cash Per Share	$1.56
Equity (Book Value)	8.42M
Book Value Per Share	1.99
Working Capital	7.34M

Cash Flow

In the last 12 months, operating cash flow was -$4.57 million and capital expenditures -$707,916, giving a free cash flow of -$5.28 million.

Operating Cash Flow	-4.57M
Capital Expenditures	-707,916
Free Cash Flow	-5.28M
FCF Per Share	-$1.22

Margins

Gross Margin	39.59%
Operating Margin	-7,397.95%
Pretax Margin	-7,915.62%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VRAX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-50.43%
Shareholder Yield	-50.43%
Earnings Yield	-130.65%
FCF Yield	-104.82%

Analyst Forecast

The average price target for VRAX is $3.00, which is 163.16% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$3.00
Price Target Difference	163.16%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on December 18, 2023. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Dec 18, 2023
Split Type	Reverse
Split Ratio	0.1:1

Scores

VRAX has an Altman Z-Score of -1.95 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.95
Piotroski F-Score	3